Brazil’s DASA says it will acquire two rival medical groups

DASA said its subsidiary Ímpar has agreed to pay about R$400 million (US$72.05 million) in cash as part of the deal, in addition to R$12.5 million in shares.

RIO DE JANEIRO, BRAZIL - Publicly traded Brazilian medical services firm Diagnósticos da América SA, known as DASA, said on Monday, March 15th, that in a securities filing that the board of the company has approved a proposed acquisition of two rival medical companies.

According to the filing, the board authorized its wholly owned subsidiary Ímpar Serviços Hospitalares SA to buy up to 100% of the stock of Andrade da Silva Participações SA and up . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?